Phenylephrine Aguettant 50 µg/ml inj. sol. i.v. pre-filled syr. Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine aguettant 50 µg/ml inj. sol. i.v. pre-filled syr.

laboratoire aguettant - phenylephrine hydrochloride 60,9 µg/ml - eq. phenylephrine 50 µg/ml - solution for injection in pre-filled syringe - 50 µg/ml - phenylephrine hydrochloride 60.9 µg/ml - phenylephrine

Phenylephrine Unimedic 0,05 mg/ml inj. sol. i.v. amp. Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 0,05 mg/ml inj. sol. i.v. amp.

unimedic pharma ab - phenylephrine hydrochloride 0,061 mg/ml - eq. phenylephrine 0,05 mg/ml - solution for injection - 0,05 mg/ml - phenylephrine hydrochloride 0.061 mg/ml - phenylephrine

Phenylephrine Unimedic 0.1 mg/ml inj. sol. i.v. amp. Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 0.1 mg/ml inj. sol. i.v. amp.

unimedic pharma ab - phenylephrine hydrochloride 0,122 mg/ml - eq. phenylephrine 0,1 mg/ml - solution for injection - 0,1 mg/ml - phenylephrine hydrochloride 0.122 mg/ml - phenylephrine

Phenylephrine Unimedic 0,1 mg/ml Solution for injection Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 0,1 mg/ml solution for injection

unimedic pharma - phenylephrine hydrochloride - solution for injection - 0,1 mg/ml - phenylephrine hydrochloride 0.122 mg/ml - phenylephrine

Phenylephrine Unimedic 10 mg/ml inj./inf. sol. (conc.) i.v. amp. Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 10 mg/ml inj./inf. sol. (conc.) i.v. amp.

unimedic pharma ab - phenylephrine hydrochloride 12,2 mg/ml - eq. phenylephrine 10 mg/ml - concentrate for solution for injection/infusion - 10 mg/ml - phenylephrine hydrochloride 12.2 mg/ml - phenylephrine

Phenylephrine Aguettant 100 µg/ml inj./inf. sol. i.v. vial Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine aguettant 100 µg/ml inj./inf. sol. i.v. vial

laboratoire aguettant - phenylephrine hydrochloride 0,122 mg/ml - eq. phenylephrine 0,1 mg/ml - solution for injection/infusion - 100 µg/ml - phenylephrine hydrochloride 0.122 mg/ml - phenylephrine

PHENYLEPHRINE HYDROCHLORIDE solution/ drops États-Unis - anglais - NLM (National Library of Medicine)

phenylephrine hydrochloride solution/ drops

lifestar pharma llc - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride ophthalmic solution 2.5%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)] . animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, caution should b

PHENYLEPHRINE HYDROCHLORIDE solution/ drops États-Unis - anglais - NLM (National Library of Medicine)

phenylephrine hydrochloride solution/ drops

lifestar pharma llc - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride ophthalmic solution, usp 10%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)]. animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, caution shoul

PHENYLEPHRINE VISION 10 % Israël - anglais - Ministry of Health

phenylephrine vision 10 %

raz pharmaceutics ltd, israel - phenylephrine hydrochloride - eye drops, solution - phenylephrine hydrochloride 100 mg / 1 ml - phenylephrine - phenylephrine vision 10 % is indicated for mydriasis and vasoconstriction.

Minims Phenylephrine Hydrochloride 2.5% w/v eye drops, solution Irlande - anglais - HPRA (Health Products Regulatory Authority)

minims phenylephrine hydrochloride 2.5% w/v eye drops, solution

bausch & lomb uk limited - phenylephrine hydrochloride - eye drops, solution - 2.5 percent weight/volume - sympathomimetics used as decongestants; phenylephrine